title: Melatonin prevents peritoneal adhesions in rats.
abstract: OBJECTIVE
  Intra-abdominal adhesions are important postoperative complications following abdominal surgery. The adhesions that develop form the basis of more advanced pathology such as intestinal obstruction or infertility. Melatonin is secreted from the pineal gland in a circadian pattern; this molecule has potent antioxidant characteristics and has beneficial effects in many models of inflammation. The aim of this study was to evaluate the effects of melatonin on peritoneal adhesions created in rats.
  
  
  METHODS
  A total of 28 Sprague-Dawley male rats were used and divided into four groups. In the first phase of the study, pinealectomy (PINX) was performed on half the animals. An incision was made and sutured in the cecum of all experimental animals in all groups 15 days after the PINX procedure. Some animals were given melatonin orally at a dose of 5 mg/kg daily following the adhesion operation and continued for 15 days. The rats were anesthetized and the abdomen opened after the 15th day (on day 30 of the study). After adhesion scoring based on macroscopic inspection, tissue samples were obtained from the sutured region of the cecum to measure malondialdehyde and hydroxyproline.
  
  
  RESULTS
  Peritoneal adhesion density was significantly higher in the PINX group compared to the control animals; exogenously administered melatonin significantly reduced adhesion formation. The degree of adhesion was also significantly lower in the intact rats given melatonin compared to the control group.
  
  
  CONCLUSIONS
  Antioxidant activity increases in the oxidative process. We conclude that melatonin may be an important molecule in preventing peritoneal adhesions.
authors.affiliation: Department of General Surgery, Gulhane Military Medical Faculty, Ankara, Turkey. nailersoz@yahoo.com
authors.forename: Nail
authors.initials: N
authors.lastname: Ersoz
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozler
authors.forename: Ozcan
authors.initials: O
authors.lastname: Altinel
authors.forename: Serdar
authors.initials: S
authors.lastname: Sadir
authors.forename: Ismail Hakki
authors.initials: IH
authors.lastname: Ozerhan
authors.forename: Bulent
authors.initials: B
authors.lastname: Uysal
authors.forename: Turgut
authors.initials: T
authors.lastname: Topal
authors.forename: Ahmet
authors.initials: A
authors.lastname: Guven
authors.forename: Ahmet
authors.initials: A
authors.lastname: Korkmaz
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage* / Q000378:metabolism; D002432:Cecum / Q000601:surgery*; D004195:Disease Models, Animal; D006909:Hydroxyproline / Q000378:metabolism; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D008550:Melatonin / Q000008:administration & dosage* / Q000378:metabolism; D010532:Peritoneal Diseases / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D010870:Pineal Gland / Q000378:metabolism / Q000601:surgery; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D000267:Tissue Adhesions
chemical_list: D000975:Antioxidants; D008315:Malondialdehyde; D008550:Melatonin; D006909:Hydroxyproline